DUBLIN--(BUSINESS WIRE)--The "Global Transcatheter Mitral Valve Replacement (TMVR) Market: 2017-2022 Edition" report has been added to Research and Markets' offering.
Global Transcatheter Mitral Valve Replacement (TMVR) Market: 2017-2022 Edition, provides analysis of the global TMVR market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value, by volume, by segments and by penetration.
The report also includes the detailed analysis of the regional TMVR market of the following regions: The US and Europe. The analysis in this segment is done by penetration, by segments, by value and by volume.
Growth of the overall global TMVR market has also been forecasted for the years 2017-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Edward Lifesciences, Medtronic, and Abbott Laboratories are some of the key players operating in the global TMVR market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Currently, the global TMVR market is in early stage, but is expected to increase at high growth rates during the forecasted period (2017-2022). The global TMVR market is supported by various growth drivers, such as aging population, high number of cases of congenital heart defects, rheumatic fever, low survival rate of surgical repair in FMR patients, etc. Yet, the market faces certain challenges, such as, complexity in design, success of repair surgery in DMR patients, high number of patients not referred for surgery, etc.
Key Topics Covered:
1. Executive Summary
3. Market Sizing
4. Regional Market Analysis
5. Competitive Landscape
6. Company Profiling
For more information about this report visit https://www.researchandmarkets.com/research/pzl5df/global